In a study by Principe and colleagues [52], global loss of TGF-β signaling protected against pancreatic tumor development via inhibition of tumor-associated fibrosis, stromal TGF-β1 production, and restoration of anti-tumor CD8+ T cells responses. This evidence concerns the gene CD8A and pancreatic neoplasm.